Prospective Observational Study Evaluating the Safety and Efficacy of Immunomodulatory Therapies in Refractory Inflammatory and Autoimmune Diseases

Not yet recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

January 15, 2025

Primary Completion Date

July 15, 2025

Study Completion Date

July 15, 2028

Conditions
Autoimmune DiseasesInflammatory Diseases
Trial Locations (17)

13005

APHM_Hôpital La Conception, Marseille

13100

Clinique Axium - Aix-en-provence, Aix-en-Provence

13915

APHM_Hôpital Nord, Marseille

14000

CHU Caen Normandie, Caen

31400

Clinique Saint-Exupéry, Saint-Exupéry

37000

CHRU de Tours_Hôpital Bretenneau, Tours

41000

CH Simone Veil de BLOIS, Blois

44000

CHU Nantes - Hotel-Dieu, Nantes

72037

CH du Mans, Le Mans

75010

APHP_Hopital Lariboisière, Paris

75012

APHP_Hôpital St Antoine, Paris

75013

APHP_ Hôpital Pitié-Salpêtrière, Paris

75018

APHP_Hôpital Bichat, Paris

76000

CHU Rouen_Hôpital Charles Nicolle, Rouen

77000

GHSIF Melun, Melun

92100

APHP_Hopital Ambroise Paré, Paris

93370

GHI Le Raincy Montfermeil, Montfermeil

All Listed Sponsors
lead

Groupe français d'étude des Maladies Inflammatoires de loeil

OTHER

NCT06757426 - Prospective Observational Study Evaluating the Safety and Efficacy of Immunomodulatory Therapies in Refractory Inflammatory and Autoimmune Diseases | Biotech Hunter | Biotech Hunter